Antonios O. Aliprantis, Ph.D. - Publications

2000 New York University, New York, NY, United States 
Microbiology Biology, Molecular Biology

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sargent JL, Li Z, Aliprantis AO, Greenblatt M, Lemaire R, Wu MH, Wei J, Taroni J, Harris A, Long KB, Burgwin C, Artlett CM, Blankenhorn EP, Lafyatis R, Varga J, et al. Interspecies comparative genomics identifies optimal mouse models of systemic sclerosis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26945694 DOI: 10.1002/art.39658  0.6
2015 Charles JF, Ermann J, Aliprantis AO. The intestinal microbiome and skeletal fitness: Connecting bugs and bones. Clinical Immunology (Orlando, Fla.). PMID 25840106 DOI: 10.1016/j.clim.2015.03.019  0.6
2015 Aliprantis AO, Charles JF, Nakamura MC. The Origins of the Osteoclast Osteoimmunology: Interactions of the Immune and Skeletal Systems: Second Edition. 5-23. DOI: 10.1016/B978-0-12-800571-2.00002-5  0.6
2014 Charles JF, Aliprantis AO. Osteoclasts: more than 'bone eaters'. Trends in Molecular Medicine. 20: 449-59. PMID 25008556 DOI: 10.1016/j.molmed.2014.06.001  0.6
2014 Ritter SY, Aliprantis AO. Relapsing polychondritis Rheumatology: Sixth Edition. 2: 1401-1405. DOI: 10.1016/B978-0-323-09138-1.00167-4  0.6
2013 Greenblatt MB, Ritter SY, Wright J, Tsang K, Hu D, Glimcher LH, Aliprantis AO. NFATc1 and NFATc2 repress spontaneous osteoarthritis. Proceedings of the National Academy of Sciences of the United States of America. 110: 19914-9. PMID 24248346 DOI: 10.1073/pnas.1320036110  0.6
2013 Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB, Goldring SR, Lee DM, Gobezie R, Aliprantis AO. Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis and Rheumatism. 65: 981-92. PMID 23400684 DOI: 10.1002/art.37823  0.6
2013 Coury F, Zenger S, Stewart AK, Stephens S, Neff L, Tsang K, Shull GE, Alper SL, Baron R, Aliprantis AO. SLC4A2-mediated Cl-/HCO3- exchange activity is essential for calpain-dependent regulation of the actin cytoskeleton in osteoclasts. Proceedings of the National Academy of Sciences of the United States of America. 110: 2163-8. PMID 23341620 DOI: 10.1073/pnas.1206392110  0.6
2013 Greenblatt MB, Aliprantis AO. The immune pathogenesis of scleroderma: context is everything. Current Rheumatology Reports. 15: 297. PMID 23288576 DOI: 10.1007/s11926-012-0297-8  0.6
2013 Greenblatt MB, Vrbanac V, Tivey T, Tsang K, Tager AM, Aliprantis AO. Correction: Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. (PLoS ONE (2012) 7, 9 (e44664) DOI:10.1371/journal.pone. 0044664) Plos One. 8. DOI: 10.1371/annotation/e413f2a1-5767-4c82-9e27-dd556155f124  0.6
2012 Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, Nakamura MC. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. The Journal of Clinical Investigation. 122: 4592-605. PMID 23114597 DOI: 10.1172/JCI60920  0.6
2012 Charles JF, Coury F, Sulyanto R, Sitara D, Wu J, Brady N, Tsang K, Sigrist K, Tollefsen DM, He L, Storm D, Aliprantis AO. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption. Bone. 51: 902-12. PMID 22985540 DOI: 10.1016/j.bone.2012.08.113  0.6
2012 Greenblatt MB, Vrbanac V, Vbranac V, Tivey T, Tsang K, Tager AM, Aliprantis AO. Graft versus host disease in the bone marrow, liver and thymus humanized mouse model. Plos One. 7: e44664. PMID 22957096 DOI: 10.1371/journal.pone.0044664  0.6
2012 Wein MN, Jones DC, Shim JH, Aliprantis AO, Sulyanto R, Lazarevic V, Poliachik SL, Gross TS, Glimcher LH. Control of bone resorption in mice by Schnurri-3. Proceedings of the National Academy of Sciences of the United States of America. 109: 8173-8. PMID 22573816 DOI: 10.1073/pnas.1205848109  0.6
2012 Greenblatt MB, Sargent JL, Farina G, Tsang K, Lafyatis R, Glimcher LH, Whitfield ML, Aliprantis AO. Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. The American Journal of Pathology. 180: 1080-94. PMID 22245215 DOI: 10.1016/j.ajpath.2011.11.024  0.6
2012 Aliprantis AO, Stolina M, Kostenuik PJ, Poliachik SL, Warner SE, Bain SD, Gross TS. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 1110-8. PMID 22125315 DOI: 10.1096/fj.11-196642  0.6
2012 Broen JC, Dieude P, Vonk MC, Beretta L, Carmona FD, Herrick A, Worthington J, Hunzelmann N, Riemekasten G, Kiener H, Scorza R, Simeon CP, Fonollosa V, Carreira P, ... ... Aliprantis AO, et al. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression. The Journal of Rheumatology. 39: 112-8. PMID 22045834 DOI: 10.3899/jrheum.110235  0.6
2011 Jones D, Glimcher LH, Aliprantis AO. Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection. The Journal of Clinical Investigation. 121: 2534-42. PMID 21737885 DOI: 10.1172/JCI46262  0.6
2010 Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A, Glimcher L, Pasparakis M, Khokha R, Ormandy CJ, Widschwendter M, Schett G, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature. 468: 98-102. PMID 20881962 DOI: 10.1038/nature09387  0.6
2010 Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. The Journal of Experimental Medicine. 207: 923-31. PMID 20421389 DOI: 10.1084/jem.20092531  0.6
2010 Sitara D, Aliprantis AO. Transcriptional regulation of bone and joint remodeling by NFAT. Immunological Reviews. 233: 286-300. PMID 20193006 DOI: 10.1111/j.0105-2896.2009.00849.x  0.6
2010 Aliprantis AO, Glimcher LH. NFATc1 in inflammatory and musculoskeletal conditions. Advances in Experimental Medicine and Biology. 658: 69-75. PMID 19950017 DOI: 10.1007/978-1-4419-1050-9_8  0.6
2008 Wu J, Glimcher LH, Aliprantis AO. HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function. Proceedings of the National Academy of Sciences of the United States of America. 105: 16934-9. PMID 18971331 DOI: 10.1073/pnas.0808763105  0.6
2008 Aliprantis AO, Ueki Y, Sulyanto R, Park A, Sigrist KS, Sharma SM, Ostrowski MC, Olsen BR, Glimcher LH. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. The Journal of Clinical Investigation. 118: 3775-89. PMID 18846253 DOI: 10.1172/JCI35711  0.6
2008 Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E. NFATc1 balances quiescence and proliferation of skin stem cells. Cell. 132: 299-310. PMID 18243104 DOI: 10.1016/j.cell.2007.11.047  0.6
2007 Aliprantis AO, Wang J, Fathman JW, Lemaire R, Dorfman DM, Lafyatis R, Glimcher LH. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proceedings of the National Academy of Sciences of the United States of America. 104: 2827-30. PMID 17307869 DOI: 10.1073/pnas.0700021104  0.6
2001 Aliprantis AO, Weiss DS, Zychlinsky A. Toll-like receptor-2 transduces signals for NF-kappa B activation, apoptosis and reactive oxygen species production. Journal of Endotoxin Research. 7: 287-91. PMID 11717583 DOI: 10.1179/096805101101532864  0.6
2001 Aliprantis AO, Weiss DS, Radolf JD, Zychlinsky A. Release of Toll-like receptor-2-activating bacterial lipoproteins in Shigella flexneri culture supernatants. Infection and Immunity. 69: 6248-55. PMID 11553567 DOI: 10.1128/IAI.69.10.6248-6255.2001  0.6
2000 Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A. The apoptotic signaling pathway activated by Toll-like receptor-2. The Embo Journal. 19: 3325-36. PMID 10880445 DOI: 10.1093/emboj/19.13.3325  0.6
1999 Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (New York, N.Y.). 285: 736-9. PMID 10426996 DOI: 10.1126/science.285.5428.736  0.6
1999 Moss JE, Aliprantis AO, Zychlinsky A. The regulation of apoptosis by microbial pathogens. International Review of Cytology. 187: 203-59. PMID 10212981  0.6
1996 Aliprantis AO, Diez-Roux G, Mulder LC, Zychlinsky A, Lang RA. Do macrophages kill through apoptosis? Immunology Today. 17: 573-6. PMID 8991289 DOI: 10.1016/S0167-5699(96)10071-2  0.6
1996 Zychlinsky A, Thirumalai K, Arondel J, Cantey JR, Aliprantis AO, Sansonetti PJ. In vivo apoptosis in Shigella flexneri infections. Infection and Immunity. 64: 5357-65. PMID 8945588  0.6
Show low-probability matches.